EMEA-001416-PIP01-12-M03
Key facts
Active substance |
Sirolimus
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0336/2021
|
PIP number |
EMEA-001416-PIP01-12-M03
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of chronic non-infectious uveitis
|
Route(s) of administration |
Intravitreal use
|
Contact for public enquiries |
Santen Incorporated
Tel. +44 1727 615110 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|